A33 shows similar sensitivity to but is more specific than CDX2 as an immunomarker of colorectal carcinoma.

Wong, Newton A C S; Adamczyk, Lukasz A; Evans, Shanna; Cullen, Jayne; Oniscu, Anca; Oien, Karin A

Wong, Newton A C S; Adamczyk, Lukasz A; Evans, Shanna; Cullen, Jayne; Oniscu, Anca; Oien, Karin A.

Affiliation

Wong NACS; Department of Cellular Pathology, Southmead Hospital, Bristol, UK.
Adamczyk LA; Department of Cellular Pathology, Southmead Hospital, Bristol, UK.
Evans S; Department of Cellular Pathology, Southmead Hospital, Bristol, UK.
Cullen J; Department of Cellular Pathology, Southmead Hospital, Bristol, UK.
Oniscu A; Department of Pathology, Royal Infirmary of Edinburgh, Edinburgh, UK.
Oien KA; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.

Histopathology ; 71(1): 34-41, 2017 Jul.

Article in En | MEDLINE | ID: mdl-28226180

Subject(s)

Adenocarcinoma/pathology; Biomarkers, Tumor/analysis; Colorectal Neoplasms/pathology; Membrane Glycoproteins/biosynthesis; CDX2 Transcription Factor/analysis; CDX2 Transcription Factor/biosynthesis; Female; Humans; Male; Membrane Glycoproteins/analysis; Sensitivity and Specificity

Key words

A33; CDX2; colorectal carcinoma; immunohistochemistry; sensitivity; specificity

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Membrane Glycoproteins / Colorectal Neoplasms / Adenocarcinoma / Biomarkers, Tumor Type of study: Diagnostic_studies Limits: Female / Humans / Male Language: En Journal: Histopathology Year: 2017 Type: Article Affiliation country: United kingdom

Fulltext

XML

PubMed Links

Search on Google